| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 12,222 | 12,269 | 11,201 | 11,892 |
| Cost of products sold | 3,435 | 3,372 | 3,033 | 2,957 |
| Selling, general and administrative | 1,789 | 1,713 | 1,584 | 1,983 |
| Research and development | 2,528 | 2,580 | 2,257 | 2,374 |
| Acquired iprd | 633 | 1,508 | 188 | 262 |
| Amortization of acquired intangible assets | 831 | 830 | 830 | 2,406 |
| Interest expense | 480 | - | - | 505 |
| Royalty income - divestitures (note 4) | 286 | - | - | 284 |
| Royalty and licensing income (note 4) | 276 | - | - | 180 |
| Provision for restructuring (note 6) | 75 | - | - | 78 |
| Investment income | 161 | - | - | 94 |
| Integration expenses (note 6) | 36 | - | - | 69 |
| Litigation and other settlements | -165 | - | - | 0 |
| Acquisition expense | 0 | - | - | 0 |
| Intangible asset impairment | 0 | - | - | - |
| Equity investment (gains)/losses, net (note 9) | 190 | - | - | 12 |
| Intangible asset impairment-Other Income | - | - | - | 47 |
| Contingent consideration (note 9) | 0 | - | - | - |
| Other | -48 | - | - | -105 |
| Other (income)/expense, net | 108 | -494 | -339 | -234 |
| Total expenses | 9,108 | 10,496 | 8,230 | 10,216 |
| Earnings/(loss) before income taxes | 3,114 | 1,773 | 2,971 | 1,676 |
| Income tax provision | 919 | 460 | 509 | 461 |
| Net earnings/(loss) | 2,195 | 1,313 | 2,462 | 1,215 |
| Noncontrolling interest | -6 | 2 | 6 | 4 |
| Net earnings/(loss) attributable to bms | 2,201 | 1,310 | 2,456 | 1,211 |
| Basic (usd per share) | 1.08 | 0.64 | 1.21 | 0.6 |
| Diluted (usd per share) | 1.08 | 0.64 | 1.2 | 0.6 |
| Weighted-average common shares outstanding basic (in shares) | 2,036,000,000 | 2,035,000,000 | 2,031,000,000 | 2,028,000,000 |
| Weighted-average common shares outstanding diluted (in shares) | 2,039,000,000 | 2,038,000,000 | 2,040,000,000 | 2,031,000,000 |
BRISTOL MYERS SQUIBB CO (BMY)
BRISTOL MYERS SQUIBB CO (BMY)